Mitzi Barmatz, MD
Urology · Tucson, AZNPI 1700888039
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $93,497 of the $135,297 with a category attached, or 69.1%. 35 manufacturers reported payments, led by Coloplast at 52.7% of the total. Reporting peaked in 2019 at $50,810 and has fallen 98.0% since, to $1,019 in 2025. Among urology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 355 payments — averaging $381.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$71K
- Caldera Medical, Inc$55K
- Neotract Inc.$2K
- Teleflex LLC$1K
- Bluewind Medical$1K
- Medtronic$923
- plus $4K from 29 others
Across 16 payments — averaging $1356.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bluewind Medical$22K
What the payments were for
- Consulting fees$93,49769%
- Travel & lodging$9,7317%
- Food & beverage$11,7469%
- Education$20,19715%
- Gifts$1260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 113 | $71,305 |
| Caldera Medical, Inc | 71 | $55,394 |
| Neotract Inc. | 14 | $1,690 |
| Teleflex LLC | 9 | $1,205 |
| Bluewind Medical | 6 | $1,150 |
| Medtronic(2 entities) | 26 | $923 |
| AbbVie(2 entities) | 20 | $471 |
| Axonics, Inc. | 10 | $455 |
| Intuitive Surgical | 5 | $413 |
| Sumitomo Pharma America, Inc. | 12 | $310 |
| Boston Scientific | 8 | $287 |
| Astellas Pharma US Inc | 13 | $277 |
| Procept Biorobotics Corporation | 3 | $270 |
| Bayer | 8 | $213 |
| Johnson & Johnson | 2 | $151 |
| Valencia Technologies Corporation | 1 | $138 |
| Dendreon Pharmaceuticals LLC | 3 | $68 |
| Endo Pharmaceuticals Inc. | 4 | $62 |
| Pfizer | 4 | $61 |
| 180 Medical, Inc. | 3 | $60 |
| AstraZeneca | 2 | $50 |
| Tolmar Pharmaceuticals, Inc. | 2 | $41 |
| Myovant Sciences Inc. | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 2 | $36 |
| Urogen Pharma, Inc. | 2 | $35 |
| Progenics Pharmaceuticals, Inc. | 1 | $28 |
| Tolmar, Inc. | 1 | $23 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $22 |
| Coopersurgical, Inc. | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $17 |
| Blue Earth Diagnostics | 1 | $17 |
| Urovant Sciences Inc | 1 | $16 |
| Amgen | 1 | $15 |
| Olympus America Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$67,843
- Desara$54,104
- Vertessa$42,829
- UroLift$2,229
- REVI$983
- RESTORELLE$600
- Saffron$478
- UroLift System$408
- Da Vinci Surgical System$366
- Axonics$259
- FEMALE INCONTINENCE$190
- INTERSTIM$181
- eCoin Device Kit$138
- BOTOX$125
- AquaBeam Robotic System$121
- Bulkamid$117
- Erleada$111
- Solyx SIS System$108
- AQUABEAM SYSTEM$103
How this compares
$135,297 in reported general payments places this provider in the 95th percentile of 269 urology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 128 | $113,884 |
| GemtesaVibegron | 98 | $97,513 |
| Estradiol | 229 | $14,369 |
| PremarinEstrogens, Conjugated | 18 | $8,061 |
| Mirabegron ErMirabegron | 14 | $6,397 |
| Methenamine Hippurate | 53 | $5,975 |
| Tamsulosin Hcl | 120 | $1,840 |
| Cephalexin | 182 | $1,514 |
| Finasteride | 78 | $1,161 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 57 | $1,133 |
| Solifenacin Succinate | 22 | $753 |
| NitrofurantoinNitrofurantoin Macrocrystal | 17 | $675 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 83 | $532 |
| Amitriptyline Hcl | 33 | $514 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 11 | $337 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $277 | $113,884128 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $310 | $97,51398 claims |
| PfizerPremarin | $61 | $8,06118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 269 urology providers in Arizona.
Other urology in Tucson
- Curtis DunsheeTucson$46K
- Susan KalotaTucson$30K
- Kalpesh PatelTucson$26K
- Tristan BerryTucson$14K
- Aleksandar BlubaumTucson$11K
- Mitchell HumphreysPhoenix$358K
- Shawn BlickGoodyear$336K
- Daniel JaffeePhoenix$280K
- Rahul MehanMesa$277K
- Chinedu MmejeGilbert$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.